We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
NICE Technology Appraisals in the NHS in England (Innovation Scorecard)
Official statistics- Frequency:
- Twice a year
- Geographic Coverage:
- England
- Geographical Granularity:
- Country, Regions, Integrated Care Boards, Sub-Integrated Care Boards, NHS Trusts
Summary
NICE Technology Appraisals in the NHS in England (Innovation Scorecard).
NHS England are working with the NHS BSA for the transfer of this publication series to the NHS BSA from April 2024.
Latest statistics
-
The Innovation Scorecard reports on the use of medicines and medicine groupings in the NHS in England, which have been positively appraised by the National...
Published: 26 October 2023
About this publication
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE). It can be used by local NHS organisations to monitor progress in implementing NICE Technology Appraisal (TA) recommendations.
Methodology
The Innovation Scorecard measures use of individual medicines and medicine groupings in the NHS in England.
The Innovation Scorecard aims to improve transparency within the NHS of what treatments recommended by NICE are available at a local level within Trusts and ICBs as well as national and NHS England Region levels. The Innovation Scorecard has been published with the intention of assisting the NHS in the identification of variation, which, through discussion, can be explained, challenged or acted upon. It is not intended to be used for performance management.
When interpreting the data there are a number of considerations:
- medicines can be used to treat multiple conditions
- a condition can be treated with various medicines
- one medicine may displace another, for example, for treatment of hepatitis C teleprevir and boceprevir is an older class of medicine and shows a large decrease in contrast to ombitasvir-paritaprevir-ritonavir that is a newer class of medicine and has increased in use
- for a typical uptake curve the rate of increase is rapid in the early years but eases off over time
Past publications
-
The Innovation Scorecard reports on the use of medicines and medicine groupings in the NHS in England, which have been positively appraised by the National...
27 April 2023
-
The Innovation Scorecard reports on the use of medicines and medicine groupings in the NHS in England, which have been positively appraised by the National...
27 October 2022
-
The Innovation Scorecard reports on the use of medicines and medicine groupings in the NHS in England, which have been positively appraised by the National...
28 April 2022
-
The Innovation Scorecard reports on the use of medicines and medicine groupings in the NHS in England, which have been positively appraised by the National...
28 October 2021
-
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National...
10 June 2021
-
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National...
8 October 2020
-
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National...
30 April 2020
-
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National...
10 October 2019
-
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National...
11 July 2019
-
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National...
11 April 2019
-
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National...
10 January 2019
-
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National...
11 October 2018
-
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National...
12 July 2018
Administrative Sources
• English Prescribing Dataset (EPD) published by the NHS Business Services Authority • Secondary Care Medicines Data (SCMD) published by the NHS Business Services Authority • Hospital Episode Statistics (HES) data from NHS England • Population data from Office for National Statistics